‘Uninhibited’ price hikes, lobbying and more: Congressional probe gives detailed look into Teva’s long run with Copaxone esagonowsky Wed, 09/30/2020…More
‘Red flag’: New info on HHS’ coronavirus ad campaign triggers renewed outcry bbulik Mon, 09/28/2020 – 10:40More
If approved, MindMed could become the second psychedelic drug development company listed on Nasdaq.More
Rite Aid said the rebranding of stores is “well underway” with a new logo inside and on the exterior of…More
The drug pricing company was valued above $19 billion on its first day on the market.More
With U.S. elections nearing, European pharma giants brace for potential pricing action: analysts esagonowsky Wed, 09/23/2020 – 14:03More
Several pharmaceutical companies have published their vaccine trial protocols. This unusually transparent action during a major drug trial deserves praise,…More
Flagship Pioneering’s David Berry founded Valo Health 18 months ago with an eye to making an AI platform to develop…More
ICER rubber-stamps Vertex’s $311K CF drug Trikafta but blasts ‘monopoly’ pricing arlene.weintraub Wed, 09/23/2020 – 09:53More
Bristol, Amgen, Teva CEOs among execs to testify at House drug pricing hearings next week esagonowsky Tue, 09/22/2020 – 11:10More
